Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ingrid Vandenput"'
Autor:
Paul H van der Horst, Yongyi Wang, Ingrid Vandenput, Liesbeth C Kühne, Patricia C Ewing, Wilfred F J van Ijcken, Marten van der Zee, Frederic Amant, Curt W Burger, Leen J Blok
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e30840 (2012)
BackgroundEvery year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with
Externí odkaz:
https://doaj.org/article/c2b97bfee31c43be916121a5f545b551
Autor:
Saskia Houterman, L.A.M. Van Lieshout, Jurgen M.J. Piek, Ingrid Vandenput, M.J.M. de Groot, Marline G. Harmsen, Sjors F.P.J. Coppus, Brenda M. Pijlman, M.C. Vos
Publikováno v:
Maturitas, 107, 1-6
Maturitas, 107, pp. 1-6
Maturitas, 107, pp. 1-6
Objective To evaluate whether opportunistic salpingectomy in premenopausal women undergoing hysterectomy for benign indications is both hormonally and surgically safe, compared with hysterectomy without salpingectomy. Study design In this multicentre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9ca6f56b475fbc49b5bf49ed32a46c
https://doi.org/10.1016/j.maturitas.2017.09.012
https://doi.org/10.1016/j.maturitas.2017.09.012
Autor:
Frédéric Amant, Janice S. Kwon, D. Mirchandani, N. M. de Lange, Ingrid Vandenput, Johanna M.A. Pijnenborg, Nicole P. M. Ezendam, L.J.M. van der Putten
Publikováno v:
Current oncology (Toronto, Ont.), 26(2), e226-e232. Multidisciplinary Digital Publishing Institute (MDPI)
Current Oncology, 26, E226-E232
Current Oncology, 26(2), E226-E232. Multimed Inc.
Current Oncology, 26(2), E226-E232. MULTIMED INC
Current Oncology
Volume 26
Issue 2
Pages 4655-232
Current Oncology, 26, 2, pp. E226-E232
Current Oncology, 26, E226-E232
Current Oncology, 26(2), E226-E232. Multimed Inc.
Current Oncology, 26(2), E226-E232. MULTIMED INC
Current Oncology
Volume 26
Issue 2
Pages 4655-232
Current Oncology, 26, 2, pp. E226-E232
Data showing the value of neoadjuvant chemotherapy (nact) followed by interval debulking surgery (ids) in the management of advanced-stage serous endometrial carcinoma (eca) are limited
the aim of the present study was to expand the knowledge ab
the aim of the present study was to expand the knowledge ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0717728e700d9fb19950141e21120ba1
https://pure.amc.nl/en/publications/neoadjuvant-chemotherapy-followed-by-surgery-for-advancedstage-endometrial-cancer(9b7a9326-dec8-404a-937b-bfebd15eb084).html
https://pure.amc.nl/en/publications/neoadjuvant-chemotherapy-followed-by-surgery-for-advancedstage-endometrial-cancer(9b7a9326-dec8-404a-937b-bfebd15eb084).html
Autor:
Christina Fotopoulou, Rabea du Bois, Ingrid Vandenput, Frédéric Amant, Andreas du Bois, Alexander Traut, Jalid Sehouli, Marco Johannes Battista, Philipp Harter, Florian Heitz, Rainer Kimmig, Annette Fisseler-Eckhoff, Pauline Wimberger, Marcus Schmidt
Publikováno v:
International journal of gynecological cancer, 24(1), 54-60. Wolters Kluwer Health
ObjectivesThis study aimed to compare the prognosis of patients with synchronous endometrial and ovarian cancer (SEOC) to matched controls with either endometrial cancer (EC) or ovarian cancer (OC).MethodsA retrospective case-control study including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840d32df9c91780bda8007021a2f5b04
https://doi.org/10.1097/igc.0000000000000019
https://doi.org/10.1097/igc.0000000000000019
Autor:
Camilla Krakstad, Solveig Tingulstad, Ingrid Vandenput, Harald Helland, Anne Cathrine Staff, Jone Trovik, Lars A. Akslen, Elisabeth Wik, Tormund S. Njolstad, Ingunn M. Stefansson, Frédéric Amant, Helga B. Salvesen, Henrica M.J. Werner, Janusz Marcickiewicz
Publikováno v:
European journal of cancer (Oxford, England, 49(16), 3431-3441. Elsevier Limited
European Journal of Cancer
European Journal of Cancer
Background: Preoperative histologic examination of tumour tissue is essential when deciding if endometrial cancer surgery should include lymph node sampling. We wanted to investigate if biomarkers could improve prediction of lymph node metastasis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec440cd3e907f30e1e2eec13d832993
https://doi.org/10.1016/j.ejca.2013.06.016
https://doi.org/10.1016/j.ejca.2013.06.016
Autor:
Bart Claes, Lars A. Akslen, Janusz Marcickiewicz, An Capoen, Amanda B. Spurdle, Philippe Moerman, Ingrid Vandenput, Helga B. Salvesen, Diego A. Garcia-Dios, Johan Van Robays, Kaltin Ferguson, Lieve Coenegrachts, Anecs, Diether Lambrechts, Penelope M. Webb, Frédéric Amant, Ignace Vergote
Publikováno v:
Gynecologic oncology, 128(2), 327-334. Academic Press Inc.
Objective. Endometrial cancer patients may benefit from systemic adjuvant chemotherapy, alone or in combination with targeted therapies. Prognostic and predictive markers are needed, however, to identify patients amenable for these therapies. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ad4e2ae956b49f60b8c5d74b368511
https://doi.org/10.1016/j.ygyno.2012.11.037
https://doi.org/10.1016/j.ygyno.2012.11.037
Autor:
Philippe Moerman, Ignace Vergote, Ben Van Calster, Thomas Vanhove, Ingrid Vandenput, Godelieve Verbist, Frédéric Amant, Toon Van Gorp
Publikováno v:
International Journal of Gynecological Cancer, 20(3), 363-367. BMJ Publishing Group
International journal of gynecological cancer, 20(3), 363-367. Wolters Kluwer Health
International journal of gynecological cancer, 20(3), 363-367. Wolters Kluwer Health
Objective: To evaluate lymphangiogenesis and lymph vessel space involvement in different subsets of endometrial cancer using podoplanin, a specific marker for lymphatic endothelium. Methods: Sixty-two patients undergoing a hysterectomy with lymphaden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3617fb2cf92e8e27006022eed6fed1a5
https://doi.org/10.1111/igc.0b013e3181d4a0b9
https://doi.org/10.1111/igc.0b013e3181d4a0b9
Autor:
Ignace Vergote, Patrick Neven, Patrick Berteloot, Ph. Moerman, Ingrid Vandenput, Frédéric Amant, B. Van Calster, Karin Leunen, An Capoen
Publikováno v:
British Journal of Cancer
British journal of cancer, 101(2), 244-249. Nature Publishing Group
British journal of cancer, 101(2), 244-249. Nature Publishing Group
BACKGROUND: To investigate the value of neoadjuvant chemotherapy (NACT), followed by interval debulking surgery (IDS), in endometrial cancer with transperitoneal spread (stage IV). METHODS: Patients with endometrial cancer with transperitoneal spread
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1849ea31845c612a448d9da48abfca4
https://doi.org/10.1038/sj.bjc.6605157
https://doi.org/10.1038/sj.bjc.6605157
Autor:
Ignace Vergote, Ingrid Vandenput, Karin Leunen, Patrick Neven, Patrick Berteloot, Frédéric Amant
Publikováno v:
International journal of gynecological cancer, 17(1), 83-87. Wolters Kluwer Health
The objective of this study was to investigate the effectiveness and toxicity of weekly topotecan in patients with recurrent epithelial ovarian cancer. Twenty patients were treated with topotecan at a dose of 4 mg/m2weekly. Efficacy was determined ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5fcfe0df7420a631362347e3902f11
https://doi.org/10.1111/j.1525-1438.2007.00789.x
https://doi.org/10.1111/j.1525-1438.2007.00789.x
Autor:
Erik A. Boss, M. Caroline Vos, Carolien Bronkhorst, Brenda M. Pijlman, Harrie W. H. Feijen, Johanna M.A. Pijnenborg, Hilde A. D. M. van Herk, Ineke M. de Kievit, Leon F.A.G. Massuger, Joke E. Haartsen, Peter E. J. de Wit, Paul J. J. M. Klinkhamer, Lonneke V. van de Poll-Franse, Nicole C.M. Visser, Ingrid Vandenput, Johan Bulten, Anneke A. M. van der Wurff, Marc P.M.L. Snijders
Publikováno v:
BMC Cancer, 15
BMC Cancer
BMC Cancer, 15:487. BioMed Central Ltd.
BMC Cancer
BMC Cancer, 15:487. BioMed Central Ltd.
Contains fulltext : 153572.pdf (Publisher’s version ) (Open Access) BACKGROUND: Endometrial carcinoma is the most common gynaecologic malignancy in industrialised countries and the incidence is still rising. Primary treatment is based on preoperati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8619366b6cf154a8a96dc4b29c7458
https://doi.org/10.1186/s12885-015-1487-3
https://doi.org/10.1186/s12885-015-1487-3